Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. - Wikidata - wikimedia - TriplyDB

Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.

Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.

http://www.wikidata.org/entity/Q37222650

about

Genomic Characterization of Metformin Hepatic Response Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes.10 Years of GWAS Discovery: Biology, Function, and Translation.Interaction between variants in the CYP2C9 and POR genes and the risk of sulfonylurea-induced hypoglycaemia: A GoDARTS Study.Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?Personalized medicine: Genetic risk prediction of drug response.The mechanisms of action of metformin.The Rotterdam Study: 2018 update on objectives, design and main results.60 years of metformin use: a glance at the past and a look to the future.Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome.INFLUENCE OF PHARMACOGENETIC POLYMORPHISMS AND DEMOGRAPHIC VARIABLES ON METFORMIN PHARMACOKINETICS IN AN ADMIXED BRAZILIAN COHORT.Mining the Genome for Therapeutic Targets.The pharmacogenetics of metformin.Genetic aetiology of glycaemic traits: approaches and insights.Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS).Genetic Variants in CPA6 and PRPF31 are Associated with Variation in Response to Metformin in Individuals with Type 2 Diabetes.Pleiotropic Effects of Metformin on Cancer

P2860

Q28554592-25FCC9B0-529C-4C00-BC51-A19DB191F7E3 Q33658321-B7692CAE-F3B5-451C-AC99-008D2B7EA783 Q38607553-F8559DE7-B6DF-4503-AC61-2E5E170BE988 Q38689236-D3C70169-B4E4-476D-A7FE-5E11FF683736 Q38705682-4E478AF3-8615-4AB0-8208-6C7CE0B9D4A8 Q38747416-3B442ED3-BA73-41CD-A778-C11555D2E1D8 Q38756015-F4AD0B97-AD9F-4455-9386-E970FF33F8AE Q41353984-A61207E3-20C9-4510-B960-7EFF98DE43AB Q47121939-7FE023B1-64ED-4523-A405-638C6C66DB74 Q48004902-CBEB0D48-DAAA-46C0-97C1-99BF469D7886 Q48006996-11BC1FE9-482A-4F59-9BCE-ECF11A6CBF44 Q48202910-DA1D11AF-4C8A-4B9E-8648-10FE39CE052D Q48295377-DE6618D2-AA58-4BA2-8F7C-A451EE516B19 Q48610822-FDB75E19-C2AD-4870-BB26-18D364E2DC9E Q49608463-0B93EB87-2102-4596-A911-B1048AA90222 Q50100048-C5D491D3-E4B1-4B99-88B0-744D1C84D771 Q53411897-D6E5001B-B75E-46FD-90BD-BE6D17937814 Q59138314-A0509813-5749-4F3B-A842-24656C96428D

P2860

Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.

http://www.wikidata.org/entity/Q37222650

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Variation in the glucose trans ...... lycemic response to metformin.

@en

Variation in the glucose trans ...... lycemic response to metformin.

@nl

type

label

Variation in the glucose trans ...... lycemic response to metformin.

@en

Variation in the glucose trans ...... lycemic response to metformin.

@nl

prefLabel

Variation in the glucose trans ...... lycemic response to metformin.

@en

Variation in the glucose trans ...... lycemic response to metformin.

@nl

P1433

Q37222650-ADE6A873-516A-4B4A-960A-DA1B5C4A7D06

P1476

Q37222650-83110DF0-CCA0-4EFC-A47D-2879EECF8570

P2093

Q37222650-100DCF41-4B55-4201-B00E-0236D655DACD

Q37222650-13B6908A-15B6-4706-9B5A-F75EDC4B85D8

Q37222650-144F9C0F-8D16-4FA8-AC39-50BC7095CA73

Q37222650-15819562-19FD-420C-B106-033F03ABBE9A

Q37222650-2F525E9C-1980-4B16-BE9C-A0D162390A81

Q37222650-37B92919-B668-4189-BBDD-36814180E8C2

Q37222650-39263FC2-392E-4B97-8C35-82D3AE78E832

Q37222650-462C2200-E0CC-464C-8C41-F810768C4AF6

Q37222650-492DDA25-0328-40B4-9D9E-7A3929823C93

Q37222650-4D71E7FD-B98F-477E-8EB0-B37CE7425499

P2860

Q37222650-07E99B8E-0A6A-438E-8F5E-2EA8A06659A0

Q37222650-0B3ECB05-1BEA-4540-8F3F-38347C55D0AC

Q37222650-0E007FD6-EE90-4BC4-8C60-92E33E3AD9B8

Q37222650-1254B9B3-0F35-45F5-BBE1-DC48C4BD82B8

Q37222650-14BE3AE8-A0D2-40A5-9379-21BBC613648D

Q37222650-196ED931-8D34-4958-A3F4-A55DFAEC76DB

Q37222650-1BA7AF66-8FDA-4015-9C99-C5130F88AC80

Q37222650-1F234AE3-4F4E-4D65-9701-2E0FC935E320

Q37222650-2645773E-D346-4B40-8009-32FC6A79D458

Q37222650-293D276A-934F-4EA3-A5B2-F0116D345470

P2888

Q37222650-616DA42D-1DB8-4544-B535-352B4E706624

P304

Q37222650-0CE7E96B-B71B-4B30-9C3E-69D2FDAA20EE

P31

Q37222650-840D1546-3F08-4512-8F94-D8B44C5F5114

P356

Q37222650-F3B95ED4-D375-4254-8F45-80E75BEF33D1

P407

Q37222650-EF9749E6-1317-4E66-8986-2E068F75EAC1

P433

Q37222650-29DBB415-A21A-43AA-9D07-466132985A1F

P478

Q37222650-BC53680E-CED4-431B-B5E7-70DE39784D2B

P50

Q37222650-08DD8ECC-5FEF-43BE-8F0A-366EB58BA585

Q37222650-10EF531E-2325-4009-8754-E609B37A10D1

Q37222650-34BDC2F1-C96F-458B-B4B2-6E73BA7C2861

Q37222650-3958AD8A-EEC8-4658-8B6A-EB50315BDDAE

Q37222650-41E71762-5ABD-4A46-8712-07334BE8A12F

Q37222650-485A2663-979A-479E-93A5-45FBB7730718

Q37222650-59317C22-4908-4DD2-B518-FD2D9A76F742

Q37222650-7E98C83C-9159-425B-8D30-33A7ED2BF8C6

Q37222650-8101A0BA-1986-4395-866A-A24B36ED2AA7

Q37222650-A0351080-5192-4D74-93F2-5E9BAAF42209

P577

Q37222650-B4D4D0FA-9D64-4198-8BD1-1148FAD3F378

P698

Q37222650-E13EDB59-30CE-4893-9C6A-FE5366DBDC35

P921

Q37222650-05b170ac-96c1-44c5-82d6-3649c95b0568

Q37222650-B2F0AA56-CB02-4FA1-813F-CF97F0A355F4

P932

Q37222650-5F8792FD-98FD-4114-86D4-A18F9A423386

P356

P1433

Nature Genetics

P1476

Variation in the glucose trans ...... lycemic response to metformin.

@en

P2093

ACCORD Investigators

http://www.w3.org/2001/XMLSchema#string

Adriaan Kooy

http://www.w3.org/2001/XMLSchema#string

Albert M Levin

http://www.w3.org/2001/XMLSchema#string

Amber A van der Heijden

http://www.w3.org/2001/XMLSchema#string

Bruno H Stricker

http://www.w3.org/2001/XMLSchema#string

Catherine E de Keyser

http://www.w3.org/2001/XMLSchema#string

Christopher J Groves

http://www.w3.org/2001/XMLSchema#string

Colin N A Palmer

http://www.w3.org/2001/XMLSchema#string

DPP Investigators

http://www.w3.org/2001/XMLSchema#string

Daniel M Rotroff

http://www.w3.org/2001/XMLSchema#string

P2860

A flexible and accurate genotype imputation method for the next generation of genome-wide association studies

Mechanism by which metformin reduces glucose production in type 2 diabetes

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

PLINK: a tool set for whole-genome association and population-based linkage analyses

Characterizing Race/Ethnicity and Genetic Ancestry for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Principal components analysis corrects for stratification in genome-wide association studies

Metformin and the gastrointestinal tract

P2888

P304

1055-1059

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG.3632

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Calum Sutherland

Nienke van Leeuwen

Alison Motsinger-Reif

P577

2016-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27500523

http://www.w3.org/2001/XMLSchema#string

P921

P932

5007158

http://www.w3.org/2001/XMLSchema#string